...
首页> 外文期刊>Chemical science >A NIR-I light-responsive superoxide radical generator with cancer cell membrane targeting ability for enhanced imaging-guided photodynamic therapy
【24h】

A NIR-I light-responsive superoxide radical generator with cancer cell membrane targeting ability for enhanced imaging-guided photodynamic therapy

机译:具有癌细胞膜靶向能力的NIR-I光响应超氧化物发生器,用于增强显影引导的光动力治疗

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Photodynamic therapy (PDT), as an emerging treatment modality, which takes advantage of reactive oxygen species (ROS) generated upon light illumination to ablate tumours, has suffered from a limited treatment depth, strong oxygen dependence and short ROS lifespan. Herein, we developed a highly efficient NIR-I light (808 nm laser) initiated theranostic system based on a fluorescent photosensitizer (EBD-1) with cancer cell membrane targeting ability, which can realize large penetration depth in tissue, generate superoxide radicals (O _(2) ~(?) ˙) to relieve the oxygen-dependence, confine the ROS oxidation at the cell membrane, and self-report the cell viability during the PDT process. In vivo experiments demonstrated that EBD-1 under 808 nm light successfully accomplished remarkable cancer ablation. This work will be beneficial for the design of novel photosensitizers for PDT-based theranostic systems.
机译:作为新出现的治疗方式的光动力疗法(PDT),其利用在光照对烧蚀肿瘤的光照上产生的反应性氧物质(ROS),遭受了有限的处理深度,强氧依赖性和短路寿命。在此,我们开发了一种基于荧光光敏剂(EBD-1)的高效的NIR-I光(808nm激光)发起的治疗系统,其具有癌细胞膜靶向能力,可以实现组织中的大型渗透深度,产生超氧化物自由基(O. _(2)〜(?)˙)以缓解氧依赖性,将ROS氧化限制在细胞膜,并在PDT过程中自我报告细胞活力。体内实验证明,808米光下的EBD-1成功完成了显着的癌症消融。这项工作将有利于设计基于PDT的Theranostic系统的新型光敏剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号